Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Clinical trial NCT00019786 · COMPLETED
Trial details
- NCT number
- NCT00019786
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-08-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.